Acetylation genotype and the genetic susceptibility to prostate cancer in a southern European population

被引:29
作者
Costa, I
Pinto, D
Morais, A
Vasconcelos, A
Oliveira, J
Lopes, C
Medeiros, R
机构
[1] Univ Minho, ICVS, Sch Hlth Sci, Life & Hlth Sci Res Inst, P-4710057 Braga, Portugal
[2] Inst Portugues Oncol Francisco Gentil, Dept Pathol, Oporto, Portugal
[3] Inst Portugues Oncol Francisco Gentil, Dept Urol, Oporto, Portugal
[4] Abel Salazar Inst Biomed Sci, ICBAS, Oporto, Portugal
关键词
NAT; polymorphisms; prostate cancer; acetylation; heterocyclic aromatic amines;
D O I
10.1002/pros.20241
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND. Epidemiologic studies have suggested that environmental factors and diet are important risk factors in the pathogenesis of prostate cancer. The N-acetyltransferases (NAT) are important enzymes in activation and inactivation of various carcinogens, including those found in well-cooked meat and cigarette smoke. METHODS. We analyzed DNA samples from 146 prostate cancer patients and 174 healthy men. We used PCR-RFLP method to analyze NAT1 and NAT2 polymorphisms. RESULTS. We did not find statistically significant differences in NATI genotypes frequencies between prostate cancer patients and control group. We observed an association of the slow acetylator genotype, NAT2*6/NAT2*6 with prostate cancer protection (P = 0.017; OR = 0,31, 95%(CI 0.11-0.84). Multivariate logistic regression analysis confirmed this association (0.030; OR = 0.32,95% CI 0.12-0.89). CONCLUSIONS. Our results indicate a role of NAT2 polymorphisms in the carcinogenic pathway of prostate cancer, specifically in a population of Southern Europe. (c) 2005 Wiley-Liss, Inc.
引用
收藏
页码:246 / 252
页数:7
相关论文
共 36 条
[21]   Human prostate epithelial cells metabolize chemicals of dietary origin to mutagens [J].
Lawson, T ;
Kolar, C .
CANCER LETTERS, 2002, 175 (02) :141-146
[22]   Metabolic susceptibility genes and prostate cancer risk in a southern European population: The role of glutathione S-transferases GSTM1,GSTM3, and GSTT1 genetic polymorphisms [J].
Medeiros, R ;
Vasconcelos, A ;
Costa, S ;
Pinto, D ;
Ferreira, P ;
Lobo, F ;
Morais, A ;
Oliveira, J ;
Lopes, C .
PROSTATE, 2004, 58 (04) :414-420
[23]   Linkage between Polymorphisms in the prostate specific antigen AREI gene region, prostate cancer risk, and circulating tumor cells [J].
Medeiros, R ;
Morais, A ;
Vasconcelos, A ;
Costa, S ;
Pinto, D ;
Oliveira, J ;
Carvalho, R ;
Lopes, C .
PROSTATE, 2002, 53 (01) :88-94
[24]   Endothelial nitric oxide synthase gene polymorphisms and genetic susceptibility to prostate cancer [J].
Medeiros, R ;
Morais, A ;
Vasconcelos, A ;
Costa, S ;
Pinto, D ;
Oliveira, J ;
Lopes, C .
EUROPEAN JOURNAL OF CANCER PREVENTION, 2002, 11 (04) :343-350
[25]   The role of vitamin D receptor gene polymorphisms in the susceptibility to prostate cancer of a southern European population [J].
Medeiros, R ;
Morais, A ;
Vasconcelos, A ;
Costa, S ;
Pinto, D ;
Oliveira, J ;
Lopes, C .
JOURNAL OF HUMAN GENETICS, 2002, 47 (08) :413-418
[26]  
MULLENBACH R, 1989, TRENDS GENET, V5, P391
[27]   Genotyping human arylamine N-acetyltransferase type 1 (NAT1) -: The identification of two novel allelic variants [J].
Payton, MA ;
Sim, E .
BIOCHEMICAL PHARMACOLOGY, 1998, 55 (03) :361-366
[28]   RISK-FACTORS FOR PROSTATE-CANCER [J].
PIENTA, KJ ;
ESPER, PS .
ANNALS OF INTERNAL MEDICINE, 1993, 118 (10) :793-803
[29]   Cancer incidence and mortality in Portugal [J].
Pinheiro, PS ;
Tyczynski, JE ;
Bray, F ;
Amado, J ;
Matos, E ;
Parkin, DM .
EUROPEAN JOURNAL OF CANCER, 2003, 39 (17) :2507-2520
[30]   Overexpressing leptin genetic polymorphism (-2548 G/A) is associated with susceptibility to prostate cancer and risk of advanced disease [J].
Ribeiro, R ;
Vasconcelos, A ;
Costa, S ;
Pinto, D ;
Morais, A ;
Oliveira, J ;
Lobo, F ;
Lopes, C ;
Medeiros, R .
PROSTATE, 2004, 59 (03) :268-274